Skip to main content
Psychedelic State(s) of America
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
All eventsSee it on the calendar

Professional Development

R.I.S.E. Summit and Working Session

Share this event

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal
An open research notebook with abstract molecular diagrams sits on a conference table, with blurred chairs in the background.

R.I.S.E. Summit and Working Session is listed as a Professional Development event in Irvine, CA, US, for November 12–13, 2026, with two sessions; the first listed session is Thursday, November 12, at 4:30 PM at AV Irvine. The R.I.S.E. Summit, the Etheridge Foundation’s inaugural conference, will showcase Research, Innovation, Science, and Education on psychedelic-assisted treatment for opioid use disorder (OUD) and addiction, highlighting the promise, challenges, and importance of this work. Listed on the MAPS events calendar, the Summit features presentations and discussion from researchers engaged in groundbreaking studies of various psychedelic medicines for addiction.

Hosted with: Psychedelic Writers Guild